Your browser doesn't support javascript.
loading
Heat inactivation of clinical COVID-19 samples on an industrial scale for low risk and efficient high-throughput qRT-PCR diagnostic testing.
Delpuech, Oona; Douthwaite, Julie A; Hill, Thomas; Niranjan, Dhevahi; Malintan, Nancy T; Duvoisin, Hannah; Elliott, Jane; Goodfellow, Ian; Hosmillo, Myra; Orton, Alexandra L; Taylor, Molly A; Brankin, Christopher; Pitt, Haidee; Ross-Thriepland, Douglas; Siek, Magdalena; Cuthbert, Anna; Richards, Ian; Ferdinand, John R; Barker, Colin; Shaw, Robert; Ariani, Cristina; Waddell, Ian; Rees, Steve; Green, Clive; Clark, Roger; Upadhyay, Abhishek; Howes, Rob.
Afiliación
  • Delpuech O; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Douthwaite JA; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Hill T; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK. Julie.douthwaite@astrazeneca.com.
  • Niranjan D; In Vivo Expressed Biologics, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK. Julie.douthwaite@astrazeneca.com.
  • Malintan NT; Charles River Laboratories, Chesterford Research Park, Saffron Walden, CB10 1XL, UK.
  • Duvoisin H; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Elliott J; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Goodfellow I; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Hosmillo M; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Orton AL; Division of Virology, Department of Pathology, Addenbrooke's Hospital, Cambridge, UK.
  • Taylor MA; Division of Virology, Department of Pathology, Addenbrooke's Hospital, Cambridge, UK.
  • Brankin C; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Pitt H; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Ross-Thriepland D; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Siek M; Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Cuthbert A; Biologics Engineering, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Richards I; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Ferdinand JR; Animal Science and Technologies, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Barker C; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Shaw R; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Ariani C; Facilities Management, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Waddell I; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Rees S; Clinical Operations, Late-Stage Development, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Green C; Charles River Laboratories, Chesterford Research Park, Saffron Walden, CB10 1XL, UK.
  • Clark R; Charles River Laboratories, Chesterford Research Park, Saffron Walden, CB10 1XL, UK.
  • Upadhyay A; Department of Medicine, University of Cambridge, Cambridge, UK.
  • Howes R; BiologIC Technologies Ltd., Soham, UK.
Sci Rep ; 12(1): 2883, 2022 02 21.
Article en En | MEDLINE | ID: mdl-35190592

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Manejo de Especímenes / Contención de Riesgos Biológicos / Inactivación de Virus / Reacción en Cadena en Tiempo Real de la Polimerasa / Prueba de Ácido Nucleico para COVID-19 / SARS-CoV-2 / COVID-19 / Calor Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Manejo de Especímenes / Contención de Riesgos Biológicos / Inactivación de Virus / Reacción en Cadena en Tiempo Real de la Polimerasa / Prueba de Ácido Nucleico para COVID-19 / SARS-CoV-2 / COVID-19 / Calor Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido